Phase I Evaluation of the Pharmacokinetics and Safety of Boceprevir and Ucalm (St John's Wort) When Co-administered to Male and Female Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 16 Jan 2013
At a glance
- Drugs Boceprevir (Primary) ; Hypericum (Primary)
- Indications Depressive disorders; Hepatitis C
- Focus Pharmacogenomic; Pharmacokinetics
- 01 Dec 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Aug 2012 New trial record
- 01 Aug 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.